Cerebrospinal fluid neuropeptides in dementia

Area of Science:

• Neuroscience
• Gerontology
• Endocrinology

Background:

• Dementia, including multi-infarct dementia (MID) and senile dementia of the Alzheimer type (SDAT), is a growing concern in the elderly population.
• Cerebrospinal fluid (CSF) neuropeptide levels, such as corticotropin-releasing hormone (CRH), thyrotropin-releasing hormone (TRH), and somatostatin (SRIF), are increasingly studied for their potential roles in cognitive impairment and mood disorders.

Purpose of the Study:

• To investigate the association between CSF concentrations of CRH, TRH, and SRIF and different types of dementia in elderly female patients.
• To determine if observed neuropeptide level changes are related to dementia severity or the presence of depressive symptoms.

Main Methods:

• CSF samples were collected from 77 female inpatients diagnosed with moderate to extreme dementia (MID and SDAT) and 17 age-matched female controls.
• Concentrations of CRH, TRH, and SRIF in CSF were quantified using immunoassay techniques.

Main Results:

• Both MID and SDAT patients exhibited significantly elevated CSF CRH and TRH levels compared to controls, with no significant difference in SRIF levels.
• Patients with simple dementia did not show elevated CRH or TRH levels.
• The most pronounced elevation in CSF CRH and TRH was observed in patients with marked depressive symptoms, irrespective of dementia type.

Conclusions:

• Elevated CSF CRH and TRH levels in elderly patients with cognitive impairment may be more strongly associated with comorbid depression than with dementia itself.
• These findings suggest a potential neuroendocrine link between depression and cognitive decline in the elderly.
• Further research is warranted to elucidate the specific mechanisms underlying these associations and their clinical implications.